We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

84 hedge funds and large institutions have $137M invested in Inovio Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 20

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

11% more funds holding

Funds holding: 76 → 84 (+8)

10% more capital invested

Capital invested by funds: $125M → $137M (+$12.5M)

0.33% more ownership

Funds ownership: 1.6% → 1.93% (+0.33%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

39% less call options, than puts

Call options by funds: $4.24M | Put options by funds: $6.92M

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
31
Reduced
20
Closed
16
Calls
$4.24M
Puts
$6.92M
Net Calls
-$2.69M
Net Calls Change
+$8.71M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$7.76M
2
Northern Trust
Northern Trust
Illinois
+$5.14M
3
CCA
Catalyst Capital Advisors
New York
+$3.69M
4
CCM
Camber Capital Management
Massachusetts
+$2.6M
5
GC
Guggenheim Capital
Illinois
+$2.36M

Top Sellers

Rank Fund Capital Flow
1
TCIM
TIAA CREF Investment Management
New York
-$4.17M
2
BG
BlackRock Group
United Kingdom
-$1.51M
3
Goldman Sachs
Goldman Sachs
New York
-$1.12M
4
Jane Street
Jane Street
New York
-$843K
5
Millennium Management
Millennium Management
New York
-$665K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$988K +$129K +1,037 +14%
EA
27
Emerald Advisers
Pennsylvania
$910K +$2.49K +20 +0.3%
SGAM
28
Smith Group Asset Management
Texas
$885K -$3.24K -26 -0.3%
AllianceBernstein
29
AllianceBernstein
Tennessee
$828K – – –
RTS
30
Round Table Services
New Jersey
$724K +$374K +3,000 +96%
AQR Capital Management
31
AQR Capital Management
Connecticut
$689K – – –
Citigroup
32
Citigroup
New York
$632K +$121K +973 +22%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$626K +$660K +5,294 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$603K – – –
HCM
35
Highbridge Capital Management
New York
$584K +$616K +4,943 New
TAM
36
Tocqueville Asset Management
New York
$561K +$380K +3,052 +180%
Group One Trading
37
Group One Trading
Illinois
$554K +$53.1K +426 +10%
AIG
38
American International Group
New York
$548K +$5.61K +45 +1%
Ameriprise
39
Ameriprise
Minnesota
$485K +$312K +2,505 +156%
LCM
40
Landscape Capital Management
New Jersey
$458K +$483K +3,875 New
NFA
41
Nationwide Fund Advisors
Ohio
$457K +$374 +3 +0.1%
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$414K -$137K -1,102 -24%
Nomura Holdings
43
Nomura Holdings
Japan
$369K -$169K -1,355 -29%
VOYA Investment Management
44
VOYA Investment Management
Georgia
$348K – – –
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$341K +$81K +650 +29%
PPA
46
Parametric Portfolio Associates
Washington
$294K +$19.6K +157 +7%
Deutsche Bank
47
Deutsche Bank
Germany
$251K +$262K +2,106 +8,424%
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$239K +$252K +2,022 New
ProShare Advisors
49
ProShare Advisors
Maryland
$235K -$56.2K -451 -18%
VKH
50
Virtu KCG Holdings
New York
$228K +$40.7K +327 +20%
1
2
3 4

INO Hedge Fund Activity: Q3 2014 in Review

84 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2014, worth a combined $137M — up 10% from $125M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new INO positions and 16 closed out — a net gain of 8 holders — while 31 added to existing stakes and 20 trimmed.

The largest buyer was Putnam Investments, opening a new position worth an estimated $7.76M. The largest seller was TIAA CREF Investment Management, cutting an estimated $4.17M.

  • 84 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2014, up from 76 in Q2 2014.
  • Funds reported $137M of Inovio Pharmaceuticals stock for Q3 2014, up 10% quarter-over-quarter.
  • 24 funds opened new Inovio Pharmaceuticals positions in Q3 2014 and 16 closed out, a net change of +8 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2014 was Putnam Investments, an estimated $7.76M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2014 was TIAA CREF Investment Management, an estimated $4.17M sold.

Based on aggregated 13F filings for Q3 2014.